Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA follow-on biologics workshop

Executive Summary

FDA schedules public workshop on "follow-on protein products" for Sept. 14 and 15. "Because of the scientific complexity of protein pharmaceutical products, FDA intends to conduct an extensive public dialogue on the scientific issues relating to the development and approval of such products," the 1FDA notice of the workshop states. The workshop will not address legal or regulatory issues. An FDA/DIA meeting on follow-on biologics is expected to take place in 2005 (2"The Pink Sheet" Aug. 9, 2004, p. 10). The workshop will be held at the University of Maryland Shady Grove Conference Center in Rockville, Md. starting at 8:30 a.m. on Sept. 14 and at 8 a.m. on Sept. 15...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044502

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel